Medical Devices Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
North America Non-Fusion Technologies Market The North American Non-Fusion Technologies market has seen challenging and dynamic market conditions. The North American Spinal Fusion & Fixation market, mainly driven by aging population and the increasing prevalence of rheumatoid and osteoarthritis.Some of the key players in The North American Non-Fusion Technologies market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asia Vertebral Compression Fracture Treatment Market The report “The Asian Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices. Some of the key players in The Asian Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Europe Vertebral Compression Fracture Treatment Market The report “The European Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices.Some of the key players in The European Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
North America Vertebral Compression Fracture Treatment Market The report “The North American Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices.Some of the key players in The North American Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
North American Pulmonary drug delivery devices Market The North American Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $13.8 billion in 2013 and expected to be $24 billion by 2018, growing at a CAGR of 11.8%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca. |
Upcoming |
|
|
European Pulmonary drug delivery devices Market The European Pulmonary Drug Delivery devices devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $7.5 billion in 2013 and expected to be $12.4billion by 2018, growing at a CAGR of 10.6%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca. |
Upcoming |
|
|
Asian Pulmonary Drug Delivery devices Market The Asian Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $7.7 billion by 2018, growing at a CAGR of 16.2%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca. |
Upcoming |
|
|
North American Active Transdermal Drug Delivery Devices Market The North American Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $712 million in 2013 and expected to be $1339 million by 2018, growing at a CAGR of 13.5 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
European Active Transdermal Drug Delivery Devices Market The European Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $353 million in 2013 and expected to be $633 million by 2018, growing at a CAGR of 12.4 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Asian Active Transdermal Drug Delivery Devices Market The Asian Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $109 million in 2013 and expected to be $188 million by 2018, growing at a CAGR of 11.6 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
North American Passive Transdermal Drug Delivery Market The North American Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $6.85 billion in 2013 and expected to be $11.33 billion by 2018, growing at a CAGR of 10.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
European Passive Transdermal Drug Delivery Market The European Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $3.27 billion in 2013 and expected to be $5.19 billion by 2018, growing at a CAGR of 9.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Asian Passive Transdermal Drug Delivery Market The Asian Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $1.40 billion in 2013 and expected to be $2.82 billion by 2018, growing at a CAGR of 15.0%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Asian Sutures Market The Asian Sutures Market was valued at $145 million in 2013 and estimated to be $169 million by 2018, at a CAGR of 3.2%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare. |
Upcoming |
|
|
European Sutures Market The European Sutures Market was valued at $233 million in 2013 and estimated to be $246 million by 2018, at a CAGR of 1.30%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare, Smith & Nephew, 3M healthcare and others. |
Upcoming |
|
|
North American Sutures Market The North American Sutures Market was valued at $705 million in 2013 and estimated to be $763 million by 2018, at a CAGR of 1.80%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare, Smith & Nephew and others. |
Upcoming |
|
|
North America Wrist Replacement Devices Market The report “North American Wrist Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Wrist Implant and Total Wrist Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Wrist osteoarthritis and rheumatoid arthritis. |
Upcoming |
|
|
Europe Wrist Replacement Devices Market The report “European Wrist Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Wrist Implant and Total Wrist Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Wrist osteoarthritis and rheumatoid arthritis. |
Upcoming |
|
|
Asia Wrist Replacement Devices Market The report “Asian Wrist Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Wrist Implant and Total Wrist Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Wrist osteoarthritis and rheumatoid arthritis. |
Upcoming |
|
|
Asia Digit Replacement Devices Market The report “Asian Digits Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Digits Replacement Implant & Devices, Digit Prosthetics and Digits Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Digits osteoarthritis and rheumatoid arthritis |
Upcoming |
infertility Treatment
